Colin L. Masters

发表

Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan

Christos Davatzikos, Sterling C. Johnson, Ilya M. Nasrallah, 2019, NeuroImage.

Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and gray matter iron distribution in Alzheimer's disease frontal cortex

Erika P. Raven, Colin L. Masters, Dominic J. Hare, 2016, NeuroImage.

Supervised method to build an atlas database for multi-atlas segmentation-propagation

Olivier Salvado, Jurgen Fripp, Fabrice Mériaudeau, 2010, Medical Imaging.

A normalisation framework for quantitative brain imaging; application to quantitative susceptibility mapping

Olivier Salvado, Jurgen Fripp, Pierrick Bourgeat, 2017, 2017 IEEE 14th International Symposium on Biomedical Imaging (ISBI 2017).

The expression of the amyloid precursor protein (APP) is regulated by two GC-elements in the promoter

Colin L. Masters, Peter Pollwein, Kornard Beyreuther, 1992, Nucleic Acids Res..

CapAIBL: Automated Reporting of Cortical PET Quantification Without Need of MRI on Brain Surface Using a Patch-Based Method

Olivier Salvado, Jurgen Fripp, Vincent Doré, 2016, Patch-MI@MICCAI.

Appearance modeling of 11C PiB PET images: Characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy aging

Sébastien Ourselin, Olivier Salvado, Marc Modat, 2008, NeuroImage.

A Framework to Objectively Identify Reference Regions for Normalizing Quantitative Imaging

Olivier Salvado, Jurgen Fripp, Pierrick Bourgeat, 2018, MICCAI.

Implementing the centiloid transformation for 11C-PiB and β-amyloid 18F-PET tracers using CapAIBL

Olivier Salvado, Jurgen Fripp, Vincent Doré, 2018, NeuroImage.

Genetic algorithm with logistic regression for prediction of progression to Alzheimer's disease

Ping Zhang, William J. Wilson, Christopher Rowe, 2014, BMC Bioinformatics.

A surface based approach for cortical thickness comparison between PiB+ and PiB- healthy control subjects

Olivier Salvado, Jurgen Fripp, Vincent Doré, 2012, Medical Imaging.

PET-only 18F-AV1451 tau quantification

Olivier Salvado, Jurgen Fripp, Vincent Doré, 2017, 2017 IEEE 14th International Symposium on Biomedical Imaging (ISBI 2017).

Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies

Vincent Doré, Pierrick Bourgeat, Colin L. Masters, 2020, NeuroImage.

Non-negative matrix factorisation improves Centiloid robustness in longitudinal studies

Jurgen Fripp, Vincent Doré, Pierrick Bourgeat, 2021, NeuroImage.

A Paradox in Digital Memory Assessment: Increased Sensitivity With Reduced Difficulty

Paul Maruff, Colin L. Masters, Adrian Schembri, 2021, Frontiers in Digital Health.

Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies

Adrian Danek, Colin L. Masters, Bernardino Ghetti, 2014, Current Neurology and Neuroscience Reports.

Association of Plasma Aß Peptides with Blood Pressure in the Elderly

Jean-François Dartigues, Colin L. Masters, David Ames, 2011, PloS one.

Alanine-2 carbonyl is an oxygen ligand in Cu2+ coordination of Alzheimer's disease amyloid-beta peptide--relevance to N-terminally truncated forms.

Colin L. Masters, C. Masters, K. Barnham, 2009, Journal of the American Chemical Society.

Associations of neighborhood environment with brain imaging outcomes in the Australian Imaging, Biomarkers and Lifestyle cohort

Christopher Fowler, Paul Maruff, Colin L. Masters, 2017, Alzheimer's & Dementia.

Iron inhibits neurotoxicity induced by trace copper and biological reductants

Xudong Huang, Colin L. Masters, Ashley I. Bush, 2004, JBIC Journal of Biological Inorganic Chemistry.

18 F-THK 523 : a novel in vivo tau imaging ligand for Alzheimer ’ s disease

Kazuhiko Yanai, Nobuyuki Okamura, Colin L. Masters, 2011 .

β-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

Paul Maruff, Colin L. Masters, William E. Klunk, 2007 .

In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease

Vincent Doré, Kazuhiko Yanai, Nobuyuki Okamura, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

The pattern of atrophy in familial Alzheimer disease

Andrew J. Saykin, Paul M. Thompson, Sébastien Ourselin, 2013, Neurology.

A{beta} burden correlates with memory impairment in non-demented subjects but plateaus in established Alzheimer's disease: A PIB-PET cross sectional study

Colin L. Masters, Greg Savage, Victor Villemagne, 2007 .

Longitudinal cognitive decline in the AIBL cohort: The role of APOE ε4 status

Paul Maruff, Colin L. Masters, Jonathan K. Foster, 2014, Neuropsychologia.

IMAGING β-AMYLOID BURDEN IN AGING AND DEMENTIA. Authors' reply

Colin L. Masters, Victor L. Villemagne, Christopher C. Rowe, 2008 .

Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease

Reisa A. Sperling, Martin N. Rossor, Chengjie Xiong, 2014, Science Translational Medicine.

Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)

Paul Maruff, Colin L. Masters, Greg Savage, 2013, International Psychogeriatrics.

Non-Aβ Component of Alzheimer's Disease Amyloid (NAC) Revisited: NAC and α-Synuclein Are Not Associated with Aβ Amyloid

Fran Maher, Colin L. Masters, Catriona McLean, 1999 .

Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease

Paul Maruff, Colin L. Masters, Greg Savage, 2013, Alzheimer's & Dementia.

Localization of Alzheimer βA4 amyloid precursor protein at central and peripheral synaptic sites

Walter Schubert, Andreas Weidemann, Colin L. Masters, 1991, Brain Research.

Alzheimer's disease

Reisa A. Sperling, Colin L. Masters, Jeffrey L. Cummings, 2015, Nature Reviews Disease Primers.

Non-invasive assessment of Alzheimer ’ s disease neurofibrillary pathology using 18 F-THK 5105 PET

Kazuhiko Yanai, Nobuyuki Okamura, Paul Yates, 2014 .

Generating continuous and categorical measures from tau imaging studies with 18F-AV1451 and 18F-THK5351: The Tau MeTeR scale

Pierrick Bourgeat, Olivier Salvado, Colin L. Masters, 2016 .

Trajectories of memory decline in preclinical Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing

Paul Maruff, Colin L. Masters, David Ames, 2015, Neurobiology of Aging.

Alzheimer’s disease amyloid beta and prion protein amyloidogenic peptides promote macrophage survival, DNA synthesis and enhanced proliferative response to CSF-1 (M-CSF)

Colin L. Masters, John A. Hamilton, Colin J. Barrow, 2002, Brain Research.

Neurodegenerative diseases and oxidative stress

Colin L. Masters, Ashley I. Bush, C. Masters, 2004, Nature Reviews Drug Discovery.

Paul Maruff, Colin L. Masters, David Ames, 2015, PloS one.

Relationship between Memory Performance and β-Amyloid Deposition at Different Stages of Alzheimer’s Disease

Gaël Chételat, Colin L. Masters, David Ames, 2012, Neurodegenerative Diseases.

Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and Dementia

Colin L. Masters, Samuel Svensson, Zsolt Cselényi, 2013, The Journal of Nuclear Medicine.

Research and standardization in Alzheimer's trials: Reaching international consensus

Paul Maruff, Colin L. Masters, David Ames, 2013, Alzheimer's & Dementia.

MR-Less Surface-Based Amyloid Assessment Based on 11C PiB PET

Olivier Salvado, Jurgen Fripp, Luping Zhou, 2014, PloS one.

Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease

Pierrick Bourgeat, Paul Maruff, Colin L. Masters, 2016, Alzheimer's & Dementia.

Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer’s disease

Colin L. Masters, Paul N. Baird, Jonathan Crowston, 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

18F-Florbetaben PET beta-amyloid binding expressed in Centiloids

Vincent Doré, Colin L. Masters, Santiago Bullich, 2017, European Journal of Nuclear Medicine and Molecular Imaging.

Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

Simone Lista, Harald Hampel, Colin L. Masters, 2018, Nature Reviews Neurology.

α-Synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease β-amyloid plaque cores

Colin L. Masters, Peter Falkai, Laszlo Havas, 1999, Neuroscience Letters.

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study

Andrew J. Saykin, Paul M. Thompson, Clifford R. Jack, 2018, The Lancet Neurology.

Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

Kathryn Goozee, Olivier Salvado, Colin L. Masters, 2018, Journal of Alzheimer's disease : JAD.

Cerebral Microbleeds: A Review of Clinical, Genetic, and Neuroimaging Associations

Patricia M. Desmond, Colin L. Masters, Victor L. Villemagne, 2013, Front. Neurol..

Addressing population aging and Alzheimer's disease through the Australian Imaging Biomarkers and Lifestyle study: Collaboration with the Alzheimer's Disease Neuroimaging Initiative

Olivier Salvado, Colin L. Masters, David Ames, 2010, Alzheimer's & Dementia.

Alzheimer's Aβ Peptides with Disease-Associated N-Terminal Modifications: Influence of Isomerisation, Truncation and Mutation on Cu2+ Coordination

Colin L. Masters, C. Masters, K. Barnham, 2010, PloS one.

Voxel-based analysis of Alzheimer's Disease using apparent fibre density

Stuart Crozier, Alan Connelly, Colin L. Masters, 2012 .

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease

Kathryn Goozee, Dag Aarsland, Colin L. Masters, 2019, Science Advances.

Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein

Andreas Weidemann, Colin L. Masters, Dirk Bunke, 1989, Cell.

A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer’s Disease

Colin L. Masters, Rachel F. Buckley, Keith A. Johnson, 2016, Journal of Molecular Neuroscience.

Rubidium and potassium levels are altered in Alzheimer’s disease brain and blood but not in cerebrospinal fluid

Colin L. Masters, Dominic J. Hare, Blaine R. Roberts, 2016, Acta neuropathologica communications.

b -amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer’s disease

Simon A. Moss, Paul Maruff, Colin L. Masters, 2007 .